Has Nadine Floyd, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,189 in general payments to Nadine Floyd, MD across 53 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nadine Floyd, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nadine Floyd, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nadine Floyd, MD

Colon & Rectal Surgery · Fort Wayne, INNPI 1821184052

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for colon & rectal surgery clinicians in IN, where the typical reported total is $1,741.

$1,189in general payments, 2019–2025

Across 53 payments — averaging $22.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$131
Johnson & Johnson$111
Axonics, Inc.$97
Merck$96
AbbVie$85
Medtronic$82
plus $587 from 18 others

What the payments were for

Food & beverage$1,189100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	2	$131
Johnson & Johnson	7	$111
Axonics, Inc.	4	$97
Merck	5	$96
AbbVie	4	$85
Medtronic(2 entities)	2	$82
TELA Bio, Inc.	3	$64
Smith+Nephew	3	$62
Aroa Biosurgery Incorporated	2	$53
Kerecis Limited	2	$52
Shire North American Group Inc	3	$46
Astellas Pharma US Inc	2	$41
Braintree Laboratories, Inc.	2	$37
Exact Sciences	1	$30
Hologic Sales And Service, LLC	1	$29
Medline Industries LP	2	$28
Azurity Pharmaceuticals, Inc.	1	$28
Takeda Pharmaceuticals U.S.A., Inc.	1	$25
Polynovo North America LLC	1	$18
THD America, Inc.	1	$17
Solventum Corporation	1	$17
Reprise Biomedical, Inc.	1	$17
Davol Inc.	1	$14
Mayne Pharma Commercial LLC	1	$8

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Da Vinci Surgical System$128

How this compares

$1,189 in reported general payments places this provider in the 40th percentile of 54 colon & rectal surgery providers in Indiana.

See all colon & rectal surgery providers in Indiana →

Medicare billing

Part B allowed, 2024

$92,079

Medicare patients

232

Services billed

549

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Mesalamine ErMesalamine	20	$10,274
LoperamideLoperamide Hcl	11	$641
Neomycin Sulfate	30	$170
Metronidazole	33	$101
Tramadol Hcl	28	$77
Fluconazole	14	$56
Oxycodone Hcl	13	$43

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Fort Wayne

Joshua WalletFort Wayne$14K
Kelly KlinkerFort Wayne$12K
Ga-Ram HanFort Wayne$9K
Mithun ShenoiFort Wayne$5K
Hisham ElhassanFort Wayne$5K
James EdlundFort Wayne$4K
Paul ConartyFort Wayne$4K
Virendra ParikhFort Wayne$3K
Glenn GoldsteinFort Wayne$3K
James ConnerFort Wayne$1K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →